MoneyWorks4Me

USFDA classifies inspection conducted at Cipla’s Goa facility as OAI

23 Jan 2020 Evaluate

United States Food and Drug Administration (USFDA) has classified the inspection conducted at Cipla’s Goa manufacturing facility from September 16-17, 2019 as Official Action Indicated (OAI). The Company will work closely with the agency to comprehensively address the observations received.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..